Current filters:  
United States
Holland & Knight
The deadline to pass a continuing resolution (CR) is Sept. 30, 2022, although weekend votes are possible. The Senate is expected to proceed with a cloture vote on the CR tonight.
Venable LLP
Does your company's health plan provide prescription drug coverage.
Jones Day
In support of the American Telemedicine Association's Telehealth Awareness Week (September 18-24, 2022), Jones Day's Digital Health team shared key insights on various legal topics...
Goodwin Procter LLP
On September 13, 2022, Lupin Ltd. announced that its RYMTI product, a biosimilar to ENBREL, has been approved in Canada.
Ankura Consulting Group LLC
On August 16, 2022, President Biden signed H.R. 5376 – Inflation Reduction Act of 2022. This new law establishes the ability for the Secretary of Health and Human Services to establish a Drug Price Negotiation Program that ...
Holland & Knight
The deadline to pass a continuing resolution (CR) is Sept. 30, 2022, although weekend votes are possible. The Senate is expected to proceed with a cloture vote on the CR tonight.
Foley & Lardner
On September 27, 2022, the Food and Drug Administration (FDA) issued its much anticipated final guidance for industry and FDA Staff, Clinical Decision Support Software.
The purpose of patents is to drive innovation. However, many jurisdictions accept that a patent term of 20 years from filing is not always sufficient to compensate an innovator for the expense...
The Food and Drug Administration (FDA) issued a guidance on development and emergency use authorization of diagnostic and serological tests for the monkeypox virus following the Secretary...
Katten Muchin Rosenman LLP
In yet another appellate court ruling, a decision by a trial court to force a hospital to issue emergency privileges to a physician in order to prescribe ivermectin to an in-patient was overturned in Pennsylvania.
Arnold & Porter
The Federal Food, Drug, and Cosmetic Act (FDCA) and the Public Health Service Act (PHSA) are the two key statutes governing the development, manufacturing, distribution, registration, licensing, clearance...
This post is the third and final installment of our blog series on the proposed regulations published by the New York State Office of Medicaid Inspector General (OMIG).
Akin Gump Strauss Hauer & Feld LLP
Extending coverage for services through CY 2023 where some benefit may exist, but insufficient evidence exists for permanent coverage...
Nexsen Pruet
On August 19, 2022, the United States Department of Health and Human Services, Department of Labor, and Department of the Treasury (the Departments) published a new final rule (Final Rule)...
Keller & Heckman
As previously covered on this blog, the U.S. District Court for the Northern District of California ruled on March 18, 2021 against a group of traditional organic farmers and the Center for Food Safety (CFS) that challenged the U.S. Department of Agriculture's (USDA) denial of their 2019 petition.
Keller & Heckman
The tomato has been modified to enhance nutritional quality and to have a purple color.
Goodwin Procter LLP
On September 12, 2022, President Biden signed the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy.
Thompson Coburn LLP
The RFI addresses several topics, including the challenges of accessing health care, advancing health equity, and provider wellbeing.
Taylor English Duma
A recent investigative report raises the question of whether our mental health system prescribes to teenagers too many psychotropic medications that haven't been tested for that age group or haven‘t been tested in combination.
Goodwin Procter LLP
This week Formycon AG ("Formycon") announced details of its previously undisclosed pipeline project for FYB206, Formycon's biosimilar of KEYTRUDA (pembrolizumab).
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media